METABOLIC EFFECTS OF THE TRIPHASIC ORAL-CONTRACEPTIVE TRIGYNONR

被引：45
作者：
VERMEULEN, A [1 ]
THIERY, M [1 ]
机构：
[1] STATE UNIV GHENT, ACAD ZIEKENHUIS, DEPT OBSTET & GYNAECOL, MED CLIN, B-9000 GHENT, BELGIUM
来源：
CONTRACEPTION | 1982年 / 26卷 / 05期
关键词：
D O I：
10.1016/0010-7824(82)90149-4
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：505 / 513
页数：9
相关论文
共 37 条
[1]  
AURELL M, 1966, LANCET, V1, P291
[2]  
BOY J, 1966, ANN BIOL CLIN, V18, P669
[3]   SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IN WOMEN USING ORAL-CONTRACEPTIVES, ESTROGENS AND PROGESTINS [J].
BRADLEY, DD ;
WINGERD, J ;
PETITTI, DB ;
KRAUSS, RM ;
RAMCHARAN, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (01) :17-20
[4]  
BRIGGS MH, 1982, BENEFITS RISKS HORMO
[5]   EFFECT OF STEROIDAL CONTRACEPTIVES ON LEVELS OF PLASMA ANDROGEN SULFATES AND CORTISOL [J].
BULBROOK, RD ;
HERIAN, M ;
TONG, D ;
HAYWARD, JL ;
SWAIN, MC ;
WANG, DY .
LANCET, 1973, 1 (7804) :628-631
[6]  
CAROL W, 1980, ENDOKRINOLOGIE, V75, P167
[7]   EVIDENCE FOR AN INFLUENCE OF THE OVARY ON CIRCULATING DEHYDROEPIANDROSTERONE SULFATE LEVELS [J].
CUMMING, DC ;
REBAR, RW ;
HOPPER, BR ;
YEN, SSC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (05) :1069-1071
[8]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[9]  
FURMAN R H, 1967, Progress in Biochemical Pharmacology, V2, P215
[10]  
GOLDMAN JA, 1969, AM J OBSTET GYNECOL, V103, P172
1234